Richard Chan Woo Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard Chan Woo Park has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Soly Baredes
Department of Otolaryngology – Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey USA
32 shared publicationsJean Anderson Eloy
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey
19 shared publications- Jacob S. Brady
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark
13 shared publications Tapan D. Patel
Department of Otolaryngology-Head and Neck Surgery, Neurological Institute of New Jersey, Newark, New Jersey, U.S.A.
8 shared publicationsEmily Marchiano
Department of Otolaryngology - Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI, USA
7 shared publicationsMeghan M. Crippen
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA
6 shared publications
Latest Publications
- 13 June 2024
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 6 (1) , 1-8
Impact of Preoperative Weight Loss On Surgical Outcomes in Patients Undergoing Glossectomies
- 13 June 2024
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 6 (1) , 1-8
Impact of Preoperative Weight Loss On Surgical Outcomes in Patients Undergoing Glossectomies
- Open Access
- 1 March 2023
- Published by Wiley in Head & Neck
- Vol. 45 (5) , 1113-1121
Opioid prescription trends among American Head and Neck Society fellowship graduates
BackgroundOpioids are commonly used to manage the pain of head and neck (HN) cancer patients. MethodsRetrospective cohort of graduates from American Head and Neck Society accredited fellowships from 1997 to 2018. The Center for Medicare and Medicaid Services Part D Provider Utilization and Payment database 2014-2019 was cross-referenced with provider names to identify opioid prescription trends. ResultsFrom 2014 to 2019, there was no significant difference in the average number of opioid beneficiaries per provider (18.02 vs. 18.10, p = 0.586) or opioid claims per provider (28.06 vs. 26.73, p = 0.708). The average total opioid day supply per beneficiary declined from 11.09 to 7.05 days from 2014 to 2019 (p < 0.001). In 2019, providers in the Northeast had the lowest prescribed opioid day supply (3.67 days) compared to those from the South who had the highest (10.32 days). ConclusionsOpioid prescription length has significantly declined among HN surgeons, with variations across geographic regions.
- 1 March 2023
- Published by Wiley in Head & Neck
- Vol. 45 (5) , 1113-1121
Open AccessOpioid prescription trends among American Head and Neck Society fellowship graduates
BackgroundOpioids are commonly used to manage the pain of head and neck (HN) cancer patients. MethodsRetrospective cohort of graduates from American Head and Neck Society accredited fellowships from 1997 to 2018. The Center for Medicare and Medicaid Services Part D Provider Utilization and Payment database 2014-2019 was cross-referenced with provider names to identify opioid prescription trends. ResultsFrom 2014 to 2019, there was no significant difference in the average number of opioid beneficiaries per provider (18.02 vs. 18.10, p = 0.586) or opioid claims per provider (28.06 vs. 26.73, p = 0.708). The average total opioid day supply per beneficiary declined from 11.09 to 7.05 days from 2014 to 2019 (p < 0.001). In 2019, providers in the Northeast had the lowest prescribed opioid day supply (3.67 days) compared to those from the South who had the highest (10.32 days). ConclusionsOpioid prescription length has significantly declined among HN surgeons, with variations across geographic regions.
- 22 December 2022
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 44 (2) , 103762
Facility volume and survival: Human papilloma virus positive oropharyngeal squamous cell carcinoma
- 22 December 2022
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 44 (2) , 103762
Facility volume and survival: Human papilloma virus positive oropharyngeal squamous cell carcinoma
- 27 December 2021
- Published by Wiley in Head & Neck
- Vol. 44 (2) , 483-493
Understanding basal cell adenocarcinoma of the head and neck: Population‐based study
Background: Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.Methods: The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.Results: Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.Conclusions: BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival.
- 27 December 2021
- Published by Wiley in Head & Neck
- Vol. 44 (2) , 483-493
Understanding basal cell adenocarcinoma of the head and neck: Population‐based study
Background: Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck.Methods: The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015.Results: Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival.Conclusions: BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival.
- 28 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 3022-3031
Exploratory analysis on the association of mental health disorders with in‐hospital postoperative complications and mortality in head and neck cancer surgery
Background The objective was to assess the association of mental health disorders with in-hospital complication and mortality rates in patients undergoing head and neck cancer surgery. Methods In this exploratory retrospective study, the Nationwide Inpatient Sample was queried from 2003 to 2014 for all patients with a diagnosis of head and neck cancer who underwent surgery. Univariate cross-tabulation, logistic regression, and propensity score matching (PSM) were used to compare demographics, procedure-related variables, and in-hospital postoperative complications and mortality between patients with and without selected comorbid mental health disorders. Results Of 39 600 included patients, 3390 (8.6%) had a selected comorbid mental health disorder diagnosis. After PSM, patients with selected mental health disorders had increased risk of overall medical complications on multivariable analysis (OR 1.28 [CI 1.12–1.46], P < 0.001) but not overall surgical complications or mortality. Conclusions Patients with a mental health disorder diagnosis have increased risk of in-hospital medical, certain surgical, and total complications.
- 28 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 3022-3031
Exploratory analysis on the association of mental health disorders with in‐hospital postoperative complications and mortality in head and neck cancer surgery
Background The objective was to assess the association of mental health disorders with in-hospital complication and mortality rates in patients undergoing head and neck cancer surgery. Methods In this exploratory retrospective study, the Nationwide Inpatient Sample was queried from 2003 to 2014 for all patients with a diagnosis of head and neck cancer who underwent surgery. Univariate cross-tabulation, logistic regression, and propensity score matching (PSM) were used to compare demographics, procedure-related variables, and in-hospital postoperative complications and mortality between patients with and without selected comorbid mental health disorders. Results Of 39 600 included patients, 3390 (8.6%) had a selected comorbid mental health disorder diagnosis. After PSM, patients with selected mental health disorders had increased risk of overall medical complications on multivariable analysis (OR 1.28 [CI 1.12–1.46], P < 0.001) but not overall surgical complications or mortality. Conclusions Patients with a mental health disorder diagnosis have increased risk of in-hospital medical, certain surgical, and total complications.
- 14 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2786-2794
Understanding giant cell sarcoma of the head and neck: A population‐based study
Background: Giant cell sarcomas (GCS) are rare head and neck neoplasms.Methods: The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for all patients who have been diagnosed with GCS from 1973 to 2014.Results: Four hundred and forty cases of GCS of the head and neck were identified. The average age at diagnosis was 74.4 years, 86.8% were white, 82.5% were male, 70.7% were insured, and 88.2% lived in an urban metropolitan region. Connective tissue was the most frequent primary site (42.5%). The 5Y‐DSS rate was 91.1%, while the 5Y‐OS was 54.6% for all cases. Patients treated with surgery alone had the highest 5Y‐DSS rate of 94.5. T‐classification odds ratio was a significant predictor of survival accounting for confounding variables on multivariate analysis.Conclusions: GCS presents most frequently in connective tissue of the head and neck with overall high probability of survival. The treatment of choice is surgery alone.
- 14 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2786-2794
Understanding giant cell sarcoma of the head and neck: A population‐based study
Background: Giant cell sarcomas (GCS) are rare head and neck neoplasms.Methods: The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for all patients who have been diagnosed with GCS from 1973 to 2014.Results: Four hundred and forty cases of GCS of the head and neck were identified. The average age at diagnosis was 74.4 years, 86.8% were white, 82.5% were male, 70.7% were insured, and 88.2% lived in an urban metropolitan region. Connective tissue was the most frequent primary site (42.5%). The 5Y‐DSS rate was 91.1%, while the 5Y‐OS was 54.6% for all cases. Patients treated with surgery alone had the highest 5Y‐DSS rate of 94.5. T‐classification odds ratio was a significant predictor of survival accounting for confounding variables on multivariate analysis.Conclusions: GCS presents most frequently in connective tissue of the head and neck with overall high probability of survival. The treatment of choice is surgery alone.
- 1 July 2020
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 41 (4) , 102464
The Affordable Care Act: Implications for underserved populations with head & neck cancer
- 1 July 2020
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 41 (4) , 102464
The Affordable Care Act: Implications for underserved populations with head & neck cancer
- 27 November 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (8) , 2008-2012
Risk assessment of hypertension in carotid body surgeries: A NSQIP analysis
Objectives Carotid body tumors (CBT) are rare paragangliomas of the carotid body at the carotid bifurcation. The purpose of this study was to determine the effect of hypertension on outcomes in carotid body tumor surgery. Study Design A retrospective database review. Methods Data on carotid body resections performed from 2005 to 2014 were drawn from the American College of Surgeons’ National Surgical Quality Improvement database. Two groups were created based on the presence of preoperative hypertension. These groups were analyzed for demographics, comorbidities, and postoperative complications using bivariate and multivariate methods. Results Of the 452 patients included in the analysis, 49.3% had hypertension. Those with hypertension were significantly more likely to have additional comorbidities, which were controlled for by multivariate analysis to focus on hypertension. These hypertensive patients also had significantly longer hospital stays. Multivariate analysis showed that patients with hypertension undergoing carotid body resections had increased risk for overall medical complications but did not have increased risk for postoperative surgical complications or specific medical complications Conclusion This statistically robust study revealed that hypertension does not independently increase a patient's risk for specific postoperative surgical complications following a carotid body tumor resection. However, hypertension increases the risk for postoperative medical complications and longer hospital stays. It is notable that almost half of all CBT patients have hypertension, and these hypertensives patients are significantly more likely to carry additional comorbid conditions that may have an adverse effect on outcomes including overall medical complications. Level of Evidence NA Laryngoscope, 2019
- 27 November 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (8) , 2008-2012
Risk assessment of hypertension in carotid body surgeries: A NSQIP analysis
Objectives Carotid body tumors (CBT) are rare paragangliomas of the carotid body at the carotid bifurcation. The purpose of this study was to determine the effect of hypertension on outcomes in carotid body tumor surgery. Study Design A retrospective database review. Methods Data on carotid body resections performed from 2005 to 2014 were drawn from the American College of Surgeons’ National Surgical Quality Improvement database. Two groups were created based on the presence of preoperative hypertension. These groups were analyzed for demographics, comorbidities, and postoperative complications using bivariate and multivariate methods. Results Of the 452 patients included in the analysis, 49.3% had hypertension. Those with hypertension were significantly more likely to have additional comorbidities, which were controlled for by multivariate analysis to focus on hypertension. These hypertensive patients also had significantly longer hospital stays. Multivariate analysis showed that patients with hypertension undergoing carotid body resections had increased risk for overall medical complications but did not have increased risk for postoperative surgical complications or specific medical complications Conclusion This statistically robust study revealed that hypertension does not independently increase a patient's risk for specific postoperative surgical complications following a carotid body tumor resection. However, hypertension increases the risk for postoperative medical complications and longer hospital stays. It is notable that almost half of all CBT patients have hypertension, and these hypertensives patients are significantly more likely to carry additional comorbid conditions that may have an adverse effect on outcomes including overall medical complications. Level of Evidence NA Laryngoscope, 2019
- 9 April 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (4) , 893-898
The “July effect”: Outcomes in microvascular reconstruction during resident transitions
Objectives/Hypothesis: To evaluate the “July effect,” as a possible risk factor for perioperative complications in otolaryngology microvascular reconstruction during the transitional period in the academic calendar.Study Design: Retrospective database review.Methods: Microvascular reconstruction outcomes in the National Surgical Quality Improvement Program (2005–2016) database were compared between the first academic quarter (July–September) to the last academic quarter (April–June). The primary outcome was 30‐day morbidity, and secondary outcomes included 30‐day mortality, operative complications, or postoperative adverse events.Results: There were 612 and 580 patients who underwent microvascular reconstruction during the first and last academic quarters, respectively. There was no significant difference between the 30‐day mortality between the first academic quarter (1.5%) and the last academic quarter (0.7%) (P = .194). There was no difference in 30‐day morbidity (47.9% vs. 49.5%, P = .586), operative complications (wound disruption, P = .151; bleeding, P = .526; operative time, P = .162), or postoperative adverse events (deep vein thrombosis, P = .460; pneumonia, P = .737; reintubation, P = .201; pulmonary embolism, P = .452; ventilation for >48 hours, P = .769; acute renal failure, P = .500; urinary tract infection, P = .693; unplanned readmission, P = .202; and mean length of stay, P = .497).Conclusions: There appears to be no July effect in microvascular reconstruction. Further studies should identify the mechanisms that preserve the safety of this operation year‐round for application to other areas of medicine who have observed the July effect.Level of Evidence: NA Laryngoscope, 130:893–898, 2020
- 9 April 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (4) , 893-898
The “July effect”: Outcomes in microvascular reconstruction during resident transitions
Objectives/Hypothesis: To evaluate the “July effect,” as a possible risk factor for perioperative complications in otolaryngology microvascular reconstruction during the transitional period in the academic calendar.Study Design: Retrospective database review.Methods: Microvascular reconstruction outcomes in the National Surgical Quality Improvement Program (2005–2016) database were compared between the first academic quarter (July–September) to the last academic quarter (April–June). The primary outcome was 30‐day morbidity, and secondary outcomes included 30‐day mortality, operative complications, or postoperative adverse events.Results: There were 612 and 580 patients who underwent microvascular reconstruction during the first and last academic quarters, respectively. There was no significant difference between the 30‐day mortality between the first academic quarter (1.5%) and the last academic quarter (0.7%) (P = .194). There was no difference in 30‐day morbidity (47.9% vs. 49.5%, P = .586), operative complications (wound disruption, P = .151; bleeding, P = .526; operative time, P = .162), or postoperative adverse events (deep vein thrombosis, P = .460; pneumonia, P = .737; reintubation, P = .201; pulmonary embolism, P = .452; ventilation for >48 hours, P = .769; acute renal failure, P = .500; urinary tract infection, P = .693; unplanned readmission, P = .202; and mean length of stay, P = .497).Conclusions: There appears to be no July effect in microvascular reconstruction. Further studies should identify the mechanisms that preserve the safety of this operation year‐round for application to other areas of medicine who have observed the July effect.Level of Evidence: NA Laryngoscope, 130:893–898, 2020
- 11 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (8) , 1822-1827
Supraglottic Squamous Cell Carcinoma: A Population‐Based Study of 22,675 Cases
Objectives/Hypothesis: The authors used the Surveillance, Epidemiology, and End Results (SEER) database to analyze epidemiological features of patients presenting with supraglottic squamous cell carcinoma (SCCa) and to evaluate treatment trends and outcomes.Methods: The SEER database was queried for patients with supraglottic SCCa from 1973 to 2013. Information on demographics; tumor size; histologic grade; American Joint Committee on Cancer (AJCC) stage; SEER local, regional, distant stage; and treatment modality were analyzed.Results: There were 22,675 cases of primary supraglottic SCCa identified. The mean age at diagnosis was 62.3 years, with males accounting for 70.3% of all cases. A high percentage of patients presented with stage IV disease (44.9%). The most common treatment modality was radiotherapy (46.6%), followed by combination of surgery and radiotherapy (29.2%) and surgery alone (15.0%). Overall 5‐year disease‐specific survival (DSS) for all cases was 54.0%. When stratified by treatment modality, 5‐year DSS was best for patients receiving surgery alone (64.2%). However, for patients with AJCC stage IV disease, survival was significantly better with combined surgery and radiotherapy (52.5%).Conclusion: In general, supraglottic SCCa is treated most commonly with radiotherapy, followed by surgery and radiotherapy. Patients managed surgically had better 5‐year DSS when compared to patients treated by other modalities. However, when stratified by stage, patients with AJCC stage IV disease had significantly better survival with combined surgery and radiotherapy. Of patients receiving surgery, supraglottic laryngectomy was found to have a significantly better 5‐year DSS when compared to both total laryngectomy and laryngectomy, not otherwise specified.Level of Evidence: NALaryngoscope, 129:1822–1827, 2019
- 11 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (8) , 1822-1827
Supraglottic Squamous Cell Carcinoma: A Population‐Based Study of 22,675 Cases
Objectives/Hypothesis: The authors used the Surveillance, Epidemiology, and End Results (SEER) database to analyze epidemiological features of patients presenting with supraglottic squamous cell carcinoma (SCCa) and to evaluate treatment trends and outcomes.Methods: The SEER database was queried for patients with supraglottic SCCa from 1973 to 2013. Information on demographics; tumor size; histologic grade; American Joint Committee on Cancer (AJCC) stage; SEER local, regional, distant stage; and treatment modality were analyzed.Results: There were 22,675 cases of primary supraglottic SCCa identified. The mean age at diagnosis was 62.3 years, with males accounting for 70.3% of all cases. A high percentage of patients presented with stage IV disease (44.9%). The most common treatment modality was radiotherapy (46.6%), followed by combination of surgery and radiotherapy (29.2%) and surgery alone (15.0%). Overall 5‐year disease‐specific survival (DSS) for all cases was 54.0%. When stratified by treatment modality, 5‐year DSS was best for patients receiving surgery alone (64.2%). However, for patients with AJCC stage IV disease, survival was significantly better with combined surgery and radiotherapy (52.5%).Conclusion: In general, supraglottic SCCa is treated most commonly with radiotherapy, followed by surgery and radiotherapy. Patients managed surgically had better 5‐year DSS when compared to patients treated by other modalities. However, when stratified by stage, patients with AJCC stage IV disease had significantly better survival with combined surgery and radiotherapy. Of patients receiving surgery, supraglottic laryngectomy was found to have a significantly better 5‐year DSS when compared to both total laryngectomy and laryngectomy, not otherwise specified.Level of Evidence: NALaryngoscope, 129:1822–1827, 2019